MDCX (Medicus Pharma) Notes Receivable: $0.00 Mil (As of Mar. 2026)


MDCX Medicus Pharma Ltd MDCX
13 GF Score
Price $0.42
! 2 Warning Signs
View Full Analysis

What is Medicus Pharma Notes Receivable?

Medicus Pharma MDCX +4.07% 13 Notes Receivable is $0.00 Mil as of Mar. 2026. GuruFocus rates MDCX with a GF Score™ of 13/100. The stock has 2 warning signs investors should review.

Medicus Pharma's Notes Receivable for the quarter that ended in Mar. 2026 was $0.00 Mil.

Medicus Pharma Notes Receivable Historical Data

* Premium members only.

The historical data trend for Medicus Pharma's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicus Pharma Notes Receivable Chart

Medicus Pharma Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
0.00 0.00 0.00 0.00 0.00

Medicus Pharma Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
MDCX
13GF Score
Medicus Pharma Ltd MDCX
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medicus Pharma Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.00 Mil mean?
Medicus Pharma (MDCX) has a Notes Receivable of $0.00 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Medicus Pharma and its competitors.
Is Medicus Pharma's Notes Receivable too high?
Medicus Pharma's current Notes Receivable is $0.00 Mil. Overall, Medicus Pharma has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Medicus Pharma's Notes Receivable compare to NSRX and MIRA?
Medicus Pharma's Notes Receivable of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Drug Manufacturers company?
A good Notes Receivable depends on the Drug Manufacturers industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Medicus Pharma and its competitors. Medicus Pharma's current Notes Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicus Pharma stock overvalued right now?
Medicus Pharma (MDCX) has a current Notes Receivable of $0.00 Mil. The current Notes Receivable is $0.00 Mil. Medicus Pharma's overall GF Score™ is 13/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Medicus Pharma (MDCX), the current Notes Receivable is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medicus Pharma Business Description

Address 100 King Street West, Suite 3400, One First Canadian Place, Toronto, ON, CAN, M5X 1A4
Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.
13GF Score

Get the complete analysis for MDCX

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.42
Price